首页> 外文期刊>Medicine. >Efficacy and safety evaluation of hyperbaric oxygen therapy for patients with ulcerative colitis
【24h】

Efficacy and safety evaluation of hyperbaric oxygen therapy for patients with ulcerative colitis

机译:高压氧治疗对溃疡性结肠炎患者的功效和安全评估

获取原文
           

摘要

BACKGROUND:Ulcerative colitis (UC) belongs to chronic colitis whose etiology and pathogenesis still have remained unclear. Hyperbaric oxygen therapy (HBOT) has been demonstrated to be effective for UC therapy. Still, evidence of its efficacy and safety is inconclusive. The purpose of the protocol is to evaluate the efficacy and safety of HBOT in UC therapy.METHODS:This systematic review will retrieve studies that meet the requirements in Embase, MEDLINE, PubMed, Web of Science, Cochrane Library Central Register of Controlled Trials, the Chinese Biomedical Literature Database (CBM), China national knowledge infrastructure database (CNKI), Wei Pu database, Wan fang database, SinoMed, Google scholar, and Baidu Scholar from their inception to November 2020. Two authors are to be independent in their article selection, data collection, and research quality assessments. The primary outcome is the clinical effectiveness. And the secondary outcomes will include 4 criteria. RevMan 5.3 software will be utilized for analysis of the data.RESULTS:The results of this study are to be submitted via a peer-reviewed journal.CONCLUSIONS:The study is to assess the effectiveness and safety of HBOT for UC and provide valid and reliable evidence regarding HBOT for UC.INPLASY REGISTRATION NUMBER:INPLASY2020100118.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:背景:溃疡性结肠炎(UC)属于慢性结肠炎,其病因和发病机制仍然不清楚。已经证明了高压氧疗法(HBOT)对UC治疗有效。尽管如此,其疗效和安全的证据是不确定的。该协议的目的是评估HBOT在UC治疗中的疗效和安全性。方法:这种系统审查将检索符合Embase,Medline,PubMed,科学网站,Cochrane图书馆中央登记册的研究的研究,中国生物医学文献数据库(CBM),中国国家知识基础设施数据库(CNKI),WEI PU数据库,万芳数据库,SINOMED,谷歌学者和百度学者从其开始到2020年11月。两位作者将独立于他们的文章选择中,数据收集和研究质量评估。主要结果是临床效果。并且二次结果将包括4个标准。 Revman 5.3软件将用于分析数据。结果:本研究的结果将通过同行评审杂志提交.Conclusions:该研究是评估UC的HBOT的有效性和安全性,并提供有效可靠的HBOT有关UC的HBOT的证据.INPLASY注册号:INPLASY2020100118.COPYRIGHT? 2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号